Hillcrest Medical Research

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia3 trials
• Gout2 trials
• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• Colorectal cancer1 trial
• COPD1 trial
• Coronary artery disease1 trial
• High blood pressure1 trial
• Lung cancer1 trial
• Stroke1 trial

Phase

• Phase 36 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed4 trials
• Recruiting4 trials
• Active, not recruiting2 trials

Lead sponsor

• Novartis Pharmaceuticals3 trials
• Boehringer Ingelheim2 trials
• Freenome Holdings Inc.2 trials
• Amgen1 trial
• Eli Lilly and Company1 trial
• and 1 more

Running trials

• Recruiting

  A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

  NCT07388498· Phase 3· Amgen· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  NCT06122077· Freenome Holdings Inc.· Source

  Contact: Study Coordinator

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

  NCT05658575· Phase 2/3· Olatec Therapeutics, Inc.· Source

  Contact: Larry Moulder

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gout2 recruiting
• COPD1 recruiting
• High blood pressure1 recruiting
• Lung cancer1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

  NCT05971940· Phase 3· Eli Lilly and Company· Source

• Completed

  Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

  NCT05763875· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Prevention of Colorectal Cancer Through Multiomics Blood Testing

  NCT04369053· Freenome Holdings Inc.· Source